Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes: advances in 1994-1995.
Berzofsky
J A
JA
Molecular Immunogenetics and Vaccine Research Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Berkower
I J
IJ
D016915:AIDS Vaccines / Q000276:immunology*; D000818:Animals; D000939:Epitopes / Q000276:immunology*; D006678:HIV / Q000276:immunology*; D015488:HIV Antigens / Q000276:immunology*; D006801:Humans; D010455:Peptides / Q000276:immunology; D010641:Phenotype; D014614:Vaccines, Synthetic / Q000276:immunology*
D016915:AIDS Vaccines; D000939:Epitopes; D015488:HIV Antigens; D010455:Peptides; D014614:Vaccines, Synthetic